We are enrolling patients in our clinical trial for a new COPD medication. Patients in this trial should have a diagnosis of moderate COPD (Chronic obstructive pulmonary disease) for at least 12 months before study entry. Participants will attend 19 study visits over the course of 64 weeks.
Patients diagnosed of moderate COPD for at least 12 months before study
5965 Transit Road, Suite 200
Buffalo, New York 14051